Search Results for: ES cell

Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification

Robin-Lovell-Badge-Peter-Braude-George-Church

The post-lunch session is “Applications of Gene Editing Technology: Human Germline Modification”. Prior to hearing it I’m curious how cautious or gung-ho the speakers will be, or if their gestalt will be one of balance in the middle somewhere. Robin Lovell-Badge, The Francis Crick Institute, was the moderator of this session. He said, “We’d be […]

Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification Read More »

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR

Human-gene-editing-science-session-small

Now we hear from the scientists on the front lines of CRISPR, covered in this post #2 of the Human Gene Editing Meeting. You can read Post #1 here. Jennifer Doudna starts off the big human gene editing science session on the current state of the human gene editing science and CRISPR. She gave an

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR Read More »

Live Blogging NAS Human Gene Editing Summit: #GeneEditSummit

Jennifer-Doudna

The National Academy of Sciences (NAS)  summit on Human Gene Editing will begin in a few days on December 1 in Washington, D.C. This summit is in part the extension of discussions that started at a more informal meeting on CRISPR earlier this year in Napa organized by Jennifer Doudna and colleagues. The NAS meeting

Live Blogging NAS Human Gene Editing Summit: #GeneEditSummit Read More »

The worst thing I’ve read all year: @Slate piece on prostate cancer

cancermyths

I’ve read a lot of bad writing in the past year including on prostate cancer. Lucky me, right? It’s probably true for most of us. However, a new piece in Slate on prostate cancer and the Movember movement (an effort that raises awareness and funds for prostate cancer research) takes the cake as the absolute worst

The worst thing I’ve read all year: @Slate piece on prostate cancer Read More »

What is Astellas Pharma, the purchaser of Ocata?

Fish-eating-fish

Astellas Pharma is on track to purchase Ocata Therapeutics (formerly Advanced Cell Technology). This has stirred a lot of strong feelings amongst investors in Ocata. (Update, now almost 5 years later, the Ocata vision program is still not going full steam ahead at its new owner it seems). I’ve also been wondering what exactly is

What is Astellas Pharma, the purchaser of Ocata? Read More »